There is one clinical trial.
The effect of caffeine on appetite and body weight is controversial. Mostly epidemiological studies exist that show either a negative effect (reduction of appetite and body weight) or no effect. In this trial we are going to study the results of the consumption of 5mgr/kgr body weight of caffeine on appetite, food consumption and hormones ghrelin, asprosin, leptin and pancreatic polypeptide in relation to gene polymorphisms that affect caffeine metabolism and body weight. Seventy subjects will participate in a cross sectional study consisting of two trials (with or without the consumption of caffeine) in order to study the aforementioned parameters. Differences of total calories consumption between fast metabolizers of caffeine and the rest of the participants is the primary outcome.
Molecular and biochemical parameters that are going to be recorded with the utilization of standardized generally accepted protocols are blood pressure, body weight and other anthropometric parameters, blood levels of ghrelin, asprosin, leptin, pancreatic polypeptide, insulin and glucose, and genetic markers that are related to caffeine metabolism (CYP1A2 rs2069514 και CYP1A2 rs762251), as well as to an obesity genetic risk score (32SNPs).
Description: a detail recording of foods and their quantities during the day of the trial will take place
Measure: total calories consumption change Time: two trials (caffeine and control) two weeks apart each lasting one dayDescription: insulin, ghrelin, asprosin, leptin and pancreatic polypeptide
Measure: hormones concentrations change Time: two trials (caffeine and control) two weeks apart each lasting one dayDescription: visual analog scales administered in specific time frames 15 min before and 15, 30, 60, 90, 120, 150, 180 min after the consumption of breakfast with or without caffeine
Measure: VAS (visual analog scale-11-likert scale with greater numbers indicating greater appetite) change for appetite Time: two trials (caffeine and control) two weeks apart each lasting one dayDescription: visual analog scales administered in specific time frames 15 min before and 15, 30, 60, 90, 120, 150, 180 min after the consumption of breakfast with or without caffeine
Measure: VAS (visual analog scale 11-likert scale with greater numbers indicating greater satiety) change for satiety Time: two trials (caffeine and control) two weeks apart each lasting one dayDescription: a detail recording of foods and their quantities during the day of the trial will take plac
Measure: various macronutrients consumption change Time: two trials (caffeine and control) two weeks apart each lasting one day